These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25312674)

  • 1. Protein stability in pulmonary drug delivery via nebulization.
    Hertel SP; Winter G; Friess W
    Adv Drug Deliv Rev; 2015 Oct; 93():79-94. PubMed ID: 25312674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
    Nasr M; Najlah M; D'Emanuele A; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. That's cool!--Nebulization of thermolabile proteins with a cooled vibrating mesh nebulizer.
    Hertel S; Pohl T; Friess W; Winter G
    Eur J Pharm Biopharm; 2014 Jul; 87(2):357-65. PubMed ID: 24662437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of protein degradation during vibrating mesh nebulization via a high throughput screening method.
    Hertel S; Pohl T; Friess W; Winter G
    Eur J Pharm Biopharm; 2014 Jul; 87(2):386-94. PubMed ID: 24709473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
    Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
    Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface active drugs significantly alter the drug output rate from medical nebulizers.
    Arzhavitina A; Steckel H
    Int J Pharm; 2010 Jan; 384(1-2):128-36. PubMed ID: 19825407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
    Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
    Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.
    Steele TW; Zhao X; Tarcha P; Kissel T
    Eur J Pharm Biopharm; 2012 Jan; 80(1):14-24. PubMed ID: 21924355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulizers for drug delivery to the lungs.
    Martin AR; Finlay WH
    Expert Opin Drug Deliv; 2015 Jun; 12(6):889-900. PubMed ID: 25534396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The function and performance of aqueous aerosol devices for inhalation therapy.
    Carvalho TC; McConville JT
    J Pharm Pharmacol; 2016 May; 68(5):556-78. PubMed ID: 27061412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery.
    Beck-Broichsitter M; Oesterheld N; Knuedeler MC; Seeger W; Schmehl T
    Int J Pharm; 2014 Jan; 461(1-2):34-7. PubMed ID: 24291081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I aerosol formulations for pulmonary delivery.
    Germershaus O; Schultz I; Lühmann T; Beck-Broichsitter M; Högger P; Meinel L
    Eur J Pharm Biopharm; 2013 Sep; 85(1):61-8. PubMed ID: 23958318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
    Sidler-Moix AL; Dolci U; Berger-Gryllaki M; Pannatier A; Cotting J; Di Paolo ER
    Pediatr Crit Care Med; 2013 Feb; 14(2):e98-102. PubMed ID: 23287904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics.
    Lehofer B; Bloder F; Jain PP; Marsh LM; Leitinger G; Olschewski H; Leber R; Olschewski A; Prassl R
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1076-85. PubMed ID: 25460154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilizing protein formulations during air-jet nebulization.
    Albasarah YY; Somavarapu S; Taylor KM
    Int J Pharm; 2010 Dec; 402(1-2):140-5. PubMed ID: 20933073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of formulation on the stability and aerosol performance of a nebulized antibody.
    Respaud R; Marchand D; Parent C; Pelat T; Thullier P; Tournamille JF; Viaud-Massuard MC; Diot P; Si-Tahar M; Vecellio L; Heuzé-Vourc'h N
    MAbs; 2014; 6(5):1347-55. PubMed ID: 25517319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients.
    Elhissi AM; Giebultowicz J; Stec AA; Wroczynski P; Ahmed W; Alhnan MA; Phoenix D; Taylor KM
    Int J Pharm; 2012 Oct; 436(1-2):519-26. PubMed ID: 22796173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol.
    Dhand R
    Respir Care; 2002 Dec; 47(12):1406-16; discussion 1416-8. PubMed ID: 12467499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.